Lv62
3100 积分 2021-08-30 加入
Drugging KRAS: current perspectives and state-of-art review
3天前
已完结
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
3天前
已完结
Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials
3天前
已完结
Tumor-Targeted Delivery of an EGFR Inhibitor Prodrug via Site-Specific Albumin Conjugation
7天前
已完结
The plasticity of mRNA translation during cancer progression and therapy resistance
10天前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer
11天前
已完结
Epigenetic Alteration of Receptor Tyrosine Kinases in Cancer
12天前
已完结
Abstract 4332: Concomitant therapy leveraging antibody-pan-KRASmt siRNA conjugate for PDAC and LUAD harboring KRAS mutations
13天前
已关闭
[General treatment of gonorrhea]
13天前
已关闭
Development of Novel Antibody–Camptothecin Conjugates
25天前
已完结
皖公网安备34019202002308
